title: Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists.
abstract: Signaling bias refers to G protein-coupled receptor ligand ability to preferentially activate one type of signal over another. Bias to evoke signaling as opposed to sequestration has been proposed as a predictor of opioid ligand potential for generating tolerance. Here we measured whether delta opioid receptor agonists preferentially inhibited cyclase activity over internalization in HEK cells. Efficacy (τ) and affinity (KA) values were estimated from functional data and bias was calculated from efficiency coefficients (log τ/KA). This approach better represented the data as compared to alternative methods that estimate bias exclusively from τ values. Log (τ/KA) coefficients indicated that SNC-80 and UFP-512 promoted cyclase inhibition more efficiently than DOR internalization as compared to DPDPE (bias factor for SNC-80: 50 and for UFP-512: 132). Molecular determinants of internalization were different in HEK293 cells and neurons with βarrs contributing to internalization in both cell types, while PKC and GRK2 activities were only involved in neurons. Rank orders of ligand ability to engage different internalization mechanisms in neurons were compared to rank order of E max values for cyclase assays in HEK cells. Comparison revealed a significant reversal in rank order for cyclase E max values and βarr-dependent internalization in neurons, indicating that these responses were ligand-specific. Despite this evidence, and because kinases involved in internalization were not the same across cellular backgrounds, it is not possible to assert if the magnitude and nature of bias revealed by rank orders of maximal responses is the same as the one measured in HEK cells.
authors.forename: Iness
authors.initials: I
authors.lastname: Charfi
authors.forename: Karim
authors.initials: K
authors.lastname: Nagi
authors.forename: Ouissame
authors.initials: O
authors.lastname: Mnie-Filali
authors.forename: Dominic
authors.initials: D
authors.lastname: Thibault
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Balboni
authors.forename: Peter W
authors.initials: PW
authors.lastname: Schiller
authors.forename: Louis-Eric
authors.initials: LE
authors.lastname: Trudeau
authors.forename: Graciela
authors.initials: G
authors.lastname: Pineyro
mesh_terms: D000704:Analysis of Variance; D001549:Benzamides / Q000494:pharmacology; D001562:Benzimidazoles / Q000494:pharmacology; D015153:Blotting, Western; D059350:Chronic Pain / Q000188:drug therapy*; D000242:Cyclic AMP / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance / Q000502:physiology*; D020881:Enkephalin, D-Penicillamine (2,5)-; D005455:Fluorescent Antibody Technique; D054769:G-Protein-Coupled Receptor Kinase 2 / Q000378:metabolism; D049452:Green Fluorescent Proteins; D057809:HEK293 Cells; D006801:Humans; D008024:Ligands; D009474:Neurons / Q000378:metabolism*; D009842:Oligopeptides / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D017465:Receptors, Opioid, delta / Q000819:agonists* / Q000378:metabolism*
chemical_list: C526539:2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (1H-benzimidazol-2-yl)(carboxymethyl)methylamide; D001549:Benzamides; D001562:Benzimidazoles; D008024:Ligands; D009842:Oligopeptides; D010879:Piperazines; D017465:Receptors, Opioid, delta; D049452:Green Fluorescent Proteins; C088464:4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide; D020881:Enkephalin, D-Penicillamine (2,5)-; D000242:Cyclic AMP; C496567:GRK2 protein, human; D054769:G-Protein-Coupled Receptor Kinase 2
references.citation: J Biol Chem. 2011 Sep 9;286(36):31731-41
references.pmid: 21757712
references.citation: Cell Signal. 2007 Jan;19(1):8-19
references.pmid: 16842969
references.citation: J Biol Chem. 2010 Apr 23;285(17):12522-35
references.pmid: 20189994
references.citation: Mol Pharmacol. 2007 Dec;72(6):1393-401
references.pmid: 17901198
references.citation: Am J Med. 2009 Oct;122(10 Suppl):S1-2
references.pmid: 19801047
references.citation: Behav Pharmacol. 2011 Sep;22(5-6):405-14
references.pmid: 21836459
references.citation: J Biol Chem. 1982 Jul 10;257(13):7847-51
references.pmid: 7085651
references.citation: PLoS One. 2009;4(5):e5425
references.pmid: 19412545
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1997 May;355(5):551-8
references.pmid: 9151291
references.citation: J Pharmacol Exp Ther. 2000 Apr;293(1):237-47
references.pmid: 10734175
references.citation: Pain. 2011 Jun;152(6):1238-1248
references.pmid: 21295407
references.citation: Brain Res Brain Res Rev. 2001 Dec;38(1-2):1-19
references.pmid: 11750924
references.citation: J Biol Chem. 2003 Aug 8;278(32):30219-26
references.pmid: 12750365
references.citation: Br J Pharmacol. 2012 Mar;165(6):1659-1669
references.pmid: 22023017
references.citation: Cell Signal. 2006 Nov;18(11):1815-33
references.pmid: 16750901
references.citation: Pharmacol Ther. 2009 Mar;121(3):285-93
references.pmid: 19100766
references.citation: Life Sci. 2003 Aug 15;73(13):1691-704
references.pmid: 12875901
references.citation: J Pharmacol Exp Ther. 2012 Sep;342(3):799-807
references.pmid: 22700431
references.citation: Br J Pharmacol. 2000 Apr;129(8):1668-72
references.pmid: 10780972
references.citation: Biochem Biophys Res Commun. 1990 Nov 15;172(3):993-9
references.pmid: 2244923
references.citation: J Neurosci. 2012 Apr 4;32(14):4827-40
references.pmid: 22492038
references.citation: FASEB J. 2010 Dec;24(12):4733-43
references.pmid: 20696855
references.citation: Clin Immunol. 2008 Oct;129(1):115-22
references.pmid: 18662895
references.citation: J Cell Mol Med. 2009 Jan;13(1):147-63
references.pmid: 18363847
references.citation: Nat Rev Drug Discov. 2013 Mar;12(3):205-16
references.pmid: 23411724
references.citation: Mol Brain. 2011 Jun 13;4:25
references.pmid: 21663702
references.citation: J Biol Chem. 2005 Mar 4;280(9):7808-16
references.pmid: 15632168
references.citation: ACS Chem Neurosci. 2012 Mar 21;3(3):193-203
references.pmid: 22860188
references.citation: J Biol Chem. 2011 Mar 18;286(11):9174-84
references.pmid: 21233215
references.citation: J Pept Res. 2002 Dec;60(6):322-8
references.pmid: 12464110
references.citation: Pharmacol Rev. 2011 Dec;63(4):1001-19
references.pmid: 21873412
references.citation: Br J Pharmacol Chemother. 1956 Dec;11(4):379-93
references.pmid: 13383117
references.citation: Expert Rev Mol Med. 2010 Apr 23;12:e13
references.pmid: 20412604
references.citation: J Biol Chem. 2007 Aug 3;282(31):22315-23
references.pmid: 17565992
references.citation: J Biol Chem. 2012 Oct 26;287(44):37066-77
references.pmid: 22965232
references.citation: Neuron. 1998 Apr;20(4):727-40
references.pmid: 9581764
references.citation: Curr Protoc Neurosci. 2008 Jul;Chapter 3:Unit 3.21
references.pmid: 18633997
references.citation: Sci Signal. 2012 Apr 24;5(221):ra33
references.pmid: 22534132
references.citation: J Neurosci. 2002 Jul 1;22(13):5769-76
references.pmid: 12097530
references.citation: Curr Opin Neurobiol. 2007 Oct;17(5):556-64
references.pmid: 18068348
references.citation: Trends Pharmacol Sci. 2011 Oct;32(10):581-90
references.pmid: 21925742
references.citation: Proc R Soc Lond B Biol Sci. 1983 Dec 22;220(1219):141-62
references.pmid: 6141562
references.citation: Eur J Pharmacol. 2003 Jan 10;459(1):9-16
references.pmid: 12505529
references.citation: J Biol Chem. 2004 Sep 3;279(36):37461-9
references.pmid: 15192107
references.citation: J Biol Chem. 2008 May 30;283(22):15078-88
references.pmid: 18381293
references.citation: Mol Pharmacol. 2011 Sep;80(3):367-77
references.pmid: 21610196
references.citation: Mol Pharmacol. 2012 Aug;82(2):178-88
references.pmid: 22553358
references.citation: J Pharmacol Exp Ther. 2007 Jan;320(1):1-13
references.pmid: 16803859
references.citation: J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):301-13
references.pmid: 10071766
references.citation: J Biol Chem. 2001 Feb 16;276(7):4709-16
references.pmid: 11085981
references.citation: Pain. 2003 Jan;101(1-2):199-208
references.pmid: 12507715
references.citation: J Biol Chem. 1996 Nov 15;271(46):29279-85
references.pmid: 8910588
references.citation: Mol Pharmacol. 2005 Jan;67(1):336-48
references.pmid: 15496503
references.citation: J Biol Chem. 1997 Dec 19;272(51):32507-12
references.pmid: 9405462
references.citation: J Neurochem. 2008 Jul;106(2):781-92
references.pmid: 18419762
references.citation: J Cell Sci. 2010 Dec 15;123(Pt 24):4259-70
references.pmid: 21098639
references.citation: J Biol Chem. 2010 Mar 5;285(10):7805-17
references.pmid: 20048153
references.citation: J Neurochem. 2009 Jun;109(5):1526-35
references.pmid: 19344370